1950s Japanese cat's brain helps Canadian researchers solve mercury poisoning mystery

In the 1950s, a Japanese cat known as "717" helped solve the mystery of a mass poisoning in Minamata, Japan.

Now, almost 70 years later, a piece of brain tissue from the same cat has led a Canadian researcher and her co-authors to believe they have solved a toxicological mystery.

Their breakthrough could eventually help save lives by treating and preventing some types of mercury poisoning.

"It was really, really cool to see how science can answer questions from the past," said Ashley James, a PhD candidate in toxicology at the University of Saskatchewan.

Minamata and Grassy Narrows poisonings not the same

James compared the Minamata case with the mercury-poisoning at Grassy Narrows (Asubpeeschoseewagong), Ontario, the site of one of Canada's worst environmental disasters. Research suggests 90 per cent of the Grassy Narrows population still experiences symptoms.

Scientists originally thought that the poisoning in Minamata was caused by the same type of mercury — methyl-mercury — as in Grassy Narrows.

James's research, based on the decades-old feline brain tissue, suggests the two poisonings were caused by different materials.

Brittany Janette/YouTube
Brittany Janette/YouTube

Starting in the 1950s, people in the city of Minamata, Japan, started showing symptoms of nervous system damage, including loss of control of bodily movements, speech and swallowing, and sometimes death.

Cats in the area were showing similar symptoms. SNC Hospital director Hajime Hosokawa wondered if wastewater from the nearby Chisso Corporation's chemical plant — which was emptied into the local seafood source of Minamata Bay — could have been responsible.

In 1959 he started experimenting on the cats, including cat 717, to test the theory that the poisoning came from eating seafood in the bay. The cats eventually started showing symptoms of neurological illness and, in the same year, a report concluded that mercury poisoning was the suspected cause of the disease in humans.

About 2,265 people have since been certified by the Japanese government as having what is now called "Minamata disease" — more than 1,700 of them have died. Beliefs exist that the number of people affected could be higher.

There are different "species" of mercury — each made up of a different molecular compound.

Knowing which compound caused the poisoning could give scientists in the medical field more knowledge to develop treatments.

Until recently, scientists thought the poisoning in Japan was caused by the less-toxic form of "inorganic" mercury, which was released from the plant and then turned into "organic" methyl-mercury when it was dumped in the water.

Synchrotron finds answers in cat brain

James's research, completed with co-author Susan Nehzati and other researchers, concludes that the Japanese poisoning was caused by a completely different type of organic mercury that was discharged directly from the plant in a deadly chemical form.

The discovery was made using the Stanford Synchrotron Radiation Lightsource, an extremely powerful x-ray machine in California.

The Associated Press
The Associated Press

"The product that we actually think was produced is something called alpha mercury acid aldehyde, which is known chemically,, like we know the structure of it, but there is nothing known about it in terms of toxicology, like how would it affect you if you consume [it]," said James.

She said the findings could help provide those answers. James hopes it can help medical scientists develop better treatment for an illness that continues to cause harm in Canada and other parts of the world.

"If you were poisoned with mercury you'd go to the hospital and they would give you a substance which kind of binds up the mercury and then you would eliminate it out of your body," said James.

"So if we can understand better how it works in your body, what it binds to, what those molecules look like, we can hopefully advance knowledge ... and possibly lead to something better in terms of treatment."

James said the next phase of her research will be to look at human brain tissue affected by mercury poisoning to build the knowledge needed to protect human populations.